- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
Clinical trial condition
DNA Virus Infections
Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.
3,921 public trials
503 recruiting studies
DNA Virus Infections trial results
NCT00888407
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +13 more
- Locations
-
- UC Davis Cancer Center Sacramento, California, United States
NCT00899496
- Conditions
- Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +122 more
- Locations
-
- Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Ghent, Belgium
NCT00601718
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +83 more
- Locations
-
- Puget Sound Oncology Consortium Seattle, Washington, United States
NCT00513474
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +72 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01110135
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
NCT00414050
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00795769
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States